Enzymes/transporters

Handbook of Experimental Pharmacology

Volumn 185, Issue PART2, 2008, Pages 131-143

  Boy, Regine Garcia ^a   Knapp, Eva Maria ^a   Eisenhut, Michael ^a   Haberkorn, Uwe ^a   Mier, Walter ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; DIAGNOSTIC AGENT; ENZYME; TUMOR MARKER;

ANIMAL; DIAGNOSTIC IMAGING; ENZYMOLOGY; GENETIC PROCEDURES; HUMAN; METABOLISM; METHODOLOGY; MOLECULAR PROBE; NEOPLASM; PATHOLOGY; REVIEW;

ANIMALS; CARRIER PROTEINS; DIAGNOSTIC IMAGING; ENZYMES; HUMANS; MOLECULAR PROBE TECHNIQUES; MOLECULAR PROBES; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84876200673     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-540-77496-9_6     Document Type: Article

References (38)

1. Bremer C, Tung CH, Weissleder R (2001) In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat Med 7(6):743-748
2. Coulibaly S et al (1999) Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C. Int J Cancer 83(4):526-531
3. Del Sole A et al (2001) Anatomical and biochemical investigation of primary brain tumours. Eur J Nucl Med 28(12):1851-1872
4. Dienel GA et al (2001) Preferential labeling of glial and meningial brain tumors with [2-(14)C] acetate. J Nucl Med 42(8):1243-1250
5. Furumoto S et al (2003) Tumor detection using 18F-labeled matrix metalloproteinase-2 inhibitor. Nucl Med Biol 30(2):119-125
6. Gutmann H et al (2000) P-glycoprotein-and mrp2-mediated octreotide transport in renal proximal tubule. Br J Pharmacol 129(2):251-256
7. Haberkorn U (1997) PET 2-fluoro-2-deoxyglucose uptake in rat prostate adenocarcinoma during chemotherapy with gemcitabine. J Nucl Med 38(8):1215-1221
8. Haberkorn U (2001) Apoptosis and changes in glucose transport early after treatment of Morris hepatoma with gemcitabine Eur J Nucl Med 28(4):418-425
9. Hartmann H (1988) Enhanced in vitro inhibition of HIV-1 replication by 3-fluoro-3-deoxythymidine compared to several other nucleoside analogs
10. Hendrikse NH (1999) Visualization of multidrug resistance in vivo. Eur J Nucl Med 26(3):283-293
11. Hu S (1998) Caspase-14 is a novel developmentally regulated protease. J Biol Chem 273(45):29648-29653
12. Hug H (1999) Rhodamine 110-linked amino acids and peptides as substrates to measure caspase activity upon apoptosis induction in intact cells. Biochemistry 38(42):13906-13911
13. Mills CO (1997) Cholyllysyl fluroscein and related lysyl fluorescein conjugated bile acid analogues Yale J Biol Med 70(4):447-457
14. Jacquier-Sarlin MR, Polla BS, Slosman DO (1996) Cellular basis of ECD brain retention. J Nucl Med 37(10):1694-1697
15. Kuhnast B (2004) Targeting of gelatinase activity with a radiolabeled cyclic HWGF peptide. Nucl Med Biol 31(3):337-444
16. Jager PL (2001) Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med 42(3):432-445
17. Kaim AH (2002) (18)F-FDG and (18)F-FET uptake in experimental soft tissue infection. Eur J Nucl Med Mol Imaging 29(5):648-654
18. Li WP (2002) DOTA-D-Tyr(1)-octreotate: a somatostatin analogue for labeling with metal and halogen radionuclides for cancer imaging and therapy. Bioconjug Chem 13(4):721-728
19. Louie AY (2000) In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol 18(3):321-325
20. MacLeod CL, Finley KD, Kakuda DK (1994) y(+)-type cationic amino acid transport: expression and regulation of the mCAT genes. J Exp Biol 196:109-121
21. Matthes E, Lehmann C, Scholz D, Rosenthal HA, Langen P (1988) Phosphorylation, anti-HIV activity and cytotoxicity of 3'-fluorothymidine. Biochem Biophys Res Commun. Jun 16; 153(2):825-31. PMID: 3164184 [PubMed-indexed for MEDLINE]
22. Miura M (1993) Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C elegans cell death gene ced-3. Cell 75(4):653-660
23. Navab R, Mort JS, Brodt P (1997) Inhibition of carcinoma cell invasion and liver metastases formation by the cysteine proteinase inhibitor E-64. Clin Exp Metastasis 15(2):121-129
24. Pauleit D (2003) Whole-body distribution and dosimetry of O-(2-[18F]fluoroethyl)-L-tyrosine. Eur J Nucl Med Mol Imaging 30(4):519-524
25. Rasey JS (2002) Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells. J Nucl Med 43(9):1210-1217
26. Redwood SM (1992) Abrogation of the invasion of human bladder tumor cells by using protease inhibitor(s). Cancer 69(5):1212-1219
27. Saha GB, MacIntyre WJ, Go RT (1994) Radiopharmaceuticals for brain imaging.Semin Nucl Med 24(4):324-493
28. Schuhmann-Giampieri G (1993) Nonlinear pharmacokinetic modeling of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging. Arzneimittelforschung 43(9):1020-1024
29. Sherman SI (2002) Optimizing the outcomes of adjuvant radioiodine therapy in differentiated thyroid carcinoma. J Clin Endocrinol Metab 87(9):4059-4062
30. Shields AF (1998) Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med 4(11):1334-1336
31. Som P (1980) A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection. J Nucl Med 21(7):670-675
32. Suolinna EM (1986) Metabolism of 2-[18F]fluoro-2-deoxyglucose in tumor-bearing rats: chromatographic and enzymatic studies. Int J Rad Appl Instrum B 13(5):577-581
33. Tung CH (1999) Preparation of a cathepsin D sensitive near-infrared fluorescence probe for imaging. Bioconjug Chem 10(5):892-896
34. Volkow ND et al (1996) PET evaluation of the dopamine system of the human brain. J Nucl Med 37(7):1242-1256
35. Walovitch RC (1989) Characterization of technetium-99m-L, L-ECD for brain perfusion imaging, Part 1: Pharmacology of technetium-99m ECD in nonhuman primates. J Nucl Med 30(11):1892-1901
36. Wester HJ (1999) Synthesis and radiopharmacology of O-(2-[18F] fluoroethyl)-L-tyrosine for tumor imaging. J Nucl Med 40(1):205-212
37. Pope LE et al (1989) Visualization of membrane-associated folate transport proteins. Adv Enzyme Regul 28:3-11
38. Yamamoto T et al (1990) Over-expression of facilitative glucose transporter genes in human cancer. Biochem Biophys Res Commun 170(1):223-230